Fecal Calprotectin Test Market Size, Share & Trends Analysis Report By Patient Type (Adult and Pediatric), By Assay Type (ELISA [Enzyme Linked Immunosorbent Assay], Enzyme Fluoroimmunoassay, and Quantitative Immune-chromatography)), By Indication, By End-user, By Region, Forecasts, 2024-2031

Report Id: 2659 Pages: 168 Last Updated: 08 August 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Fecal Calprotectin Test Market-

Fecal Calprotectin Test Market- By Patient Type

  • Adult
  • Pediatric

fecal calprotectin test

Fecal Calprotectin Test Market- By Assay Type

  • ELISA (Enzyme-linked Immunosorbent Assay)
  • Enzyme Fluoroimmunoassay
  • Quantitative Immune-Chromatography

Fecal Calprotectin Test Market- By Indication

  • Inflammatory Bowel Disease
  • Colorectal Cancer
  • Celiac Disease

Fecal Calprotectin Test Market- By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Academic & Research Institutes

Fecal Calprotectin Test Market- By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Fecal Calprotectin Test Market Snapshot

Chapter 4. Global Fecal Calprotectin Test Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Patient Type Estimates & Trend Analysis
5.1. By Patient Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Patient Type:

5.2.1. Adult
5.2.2. Pediatric

Chapter 6. Market Segmentation 2: By Assay Type Estimates & Trend Analysis
6.1. By Assay Type & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Assay Type:

6.2.1. ELISA (Enzyme linked Immunosorbent Assay)
6.2.2. Enzyme Fluoroimmunoassay
6.2.3. Quantitative Immune-chromatography

Chapter 7. Market Segmentation 3: By Indication Estimates & Trend Analysis
7.1. By Indication & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Indication:

7.2.1. Inflammatory Bowel Disease
7.2.2. Colorectal Cancer
7.2.3. Celiac Disease

Chapter 8. Market Segmentation 4: by End User Estimates & Trend Analysis
8.1. by End User & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:

8.2.1. Hospitals
8.2.2. Diagnostic Laboratories
8.2.3. Academic & Research Institutes

Chapter 9. Fecal Calprotectin Test Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America
9.1.1. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.1.2. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.1.3. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.1.4. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.1.5. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

9.2. Europe
9.2.1. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.2.2. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.2.3. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.2.4. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.2.5. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

9.3. Asia Pacific
9.3.1. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.3.2. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.3.3. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.3.4. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.3.5. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

9.4. Latin America
9.4.1. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.4.2. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.4.3. Latin America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.4.4. Latin America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.4.5. Latin America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

9.5. Middle East & Africa
9.5.1. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.5.2. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.5.3. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.5.4. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.5.5. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles

10.2.1. Abbexa
10.2.2. ALPCO
10.2.3. Alpha Laboratories
10.2.4. Biomerica
10.2.5. BÜHLMANN Laboratories AG
10.2.6. DRG Instruments GmbH
10.2.7. EagleBio
10.2.8. Epitope Diagnostics, Inc.
10.2.9. OPERON, S.A.
10.2.10. R-Biopharm AG
10.2.11. Svar Life Science
10.2.12. Thermo Fisher Scientific Inc.
10.2.13. Werfen
10.2.14. SENTINEL CH. SpA
10.2.15. Diazyme Laboratories, Inc.
10.2.16. DiAgam
10.2.17. Other Prominent Players


Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
4190
Security Code field cannot be blank!

Frequently Asked Questions

The Fecal Calprotectin Test Market Size was valued at USD 140.2 Mn in 2023 and is predicted to reach USD 280.5 Mn by 2031

The Fecal Calprotectin Test Market is expected to grow at a 9.17% CAGR during the forecast period for 2024-2031.

Abbexa, ALPCO, Alpha Laboratories, Biomerica, BÜHLMANN Laboratories AG, DRG INSTRUMENTS GMBH, EagleBio, Epitope Diagnostics, Inc., OPERON, S.A., R-Bio

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying